Jim Stanker | CFO |
David Young | President & CEO |
Francois Brisebois | Oppenheimer |
Naz Rahman | Maxim Group |
Greetings, and welcome to Processa Pharmaceuticals third-quarter 2022 earnings call and corporate update. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation.
As a reminder, this call is being recorded. It is now my pleasure to introduce Jim Stanker, Chief Financial Officer.